Bioventus Inc (BVS)
11.64
+0.59
(+5.34%)
USD |
NASDAQ |
Sep 27, 16:00
11.65
+0.01
(+0.09%)
After-Hours: 20:00
Bioventus Cash and Short Term Investments (Quarterly): 31.99M for June 30, 2024
Cash and Short Term Investments (Quarterly) Chart
Historical Cash and Short Term Investments (Quarterly) Data
Date | Value |
---|---|
June 30, 2024 | 31.99M |
March 31, 2024 | 25.17M |
December 31, 2023 | 36.96M |
September 30, 2023 | 26.83M |
June 30, 2023 | 29.39M |
March 31, 2023 | 47.10M |
December 31, 2022 | 30.19M |
September 30, 2022 | 34.36M |
June 30, 2022 | 41.00M |
Date | Value |
---|---|
March 31, 2022 | 27.37M |
December 31, 2021 | 43.93M |
September 30, 2021 | 80.92M |
June 30, 2021 | 136.06M |
March 31, 2021 | 124.25M |
December 31, 2020 | 86.84M |
September 30, 2020 | 72.48M |
December 31, 2019 | 64.52M |
March 31, 2016 | 6.166M |
Cash and Short Term Investments Definition
Cash and Short Term investments is the sum of two balance sheet line items: cash and equivalents and short term investments in marketable securities.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
25.17M
Minimum
Mar 2024
136.06M
Maximum
Jun 2021
55.26M
Average
41.00M
Median
Jun 2022
Cash and Short Term Investments (Quarterly) Benchmarks
Perspective Therapeutics Inc | 292.87M |
Retractable Technologies Inc | 41.90M |
InfuSystems Holdings Inc | 0.146M |
Xtant Medical Holdings Inc | 5.379M |
Catheter Precision Inc | 0.016M |